NUCLEON SITE SELECTION CRITERIA
The study feasibility is an integral and critical initial step in the conduct of any clinical trial efficiently. By assessing potential investigators at the site level, we have a more accurate analysis of their workload and competing studies. Our proven comprehensive site support model involves placing a full-time, highly qualified clinical research coordinator at each study site to assist the investigators and site staff with all day-to-day study conduct activities.
Investigator Selection Criteria:
Our Network
Accelerating Recruitment & Retention Strategy in Clinical Trialsthrough Patient Support Programs (PSPs) 24×7 inbound Medical Information Call center (MICC). PSPs are an ideal way for you to directly support patients, improve adherence and optimize efficacy and outcomes for Clinical Trials.
Five key needs that our comprehensive patient support programs address.
Clinical: Providing patients with a point of contact during trials and assisting with transitioning from clinical to commercial drugs, specifically clinical trial support and risk evaluation and mitigation strategies.
Engagement: Specific engagement related solutions include enrollment and consent, case management, patient adherence programs, portals, assistance with appointments and scheduling, mobile health monitoring, telehealth, and advocacy.
Therapy: Connecting with patients to provide access to and support with their care. Specific therapy-related solutions include access to care, specialty pharmacy triage, distribution solutions, site of care/infusion site match, lab/test results coordination, and nurse visits.
Financial: Specific financial solutions include insurance verification, benefits investigation, claims appeals and re-coding, prior authorization, co-pay assistance, and bridge therapy programs.
Education: Solutions include medical information and pharmacovigilance, nursing educational support, and between-visit care.